FindTrial
Sign In

Effect of a High Protein Powders on 2 hours Glucose Response

Evaluation of Glycemic Index of High Protein Powders-Celevida Maxx DLS,Celevida Maxx Liv, Celevida Maxx EN

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/09/036565
Enrollment
15
Registered
2021-09-16
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Celevida - High Protein Powders: Three variants of High Protein Powders (Celevida Maxx DLS,Celevida Maxx Liv and Celevida Maxx EN) will be given to study participants. Test foods provid

Sponsors

Madras Diabetes Research Foundation
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: �BMI �22.9 kg/ m2 �Both male and female �Willingness to consume the test foods �no known food allergy or intolerance; �no medications known to affect glucose tolerance (excluding oral contraceptives) � stable doses of oral contraceptives, acetylsalicylic acid, thyroxin, vitamins and mineral supplements or drugs to treat hypertension or osteoporosis are acceptable

Exclusion criteria

Exclusion criteria: �a known history of diabetes mellitus or the use of antihyperglycemic drugs or insulin to treat diabetes and related conditions �pregnant or lactating women �a major medical or surgical event requiring hospitalization within the preceding 3 months; �the presence of disease or drug(s) which influence digestion and absorption of nutrients; �the use of steroids, protease inhibitors or antipsychotics (all of which have major effects on glucose metabolism and body fat distribution).

Design outcomes

Primary

MeasureTime frame
The glycemic index, GI category of food productsTimepoint: 3 months—

Secondary

MeasureTime frame
Assessing the proximates and available carbohydrates of food productsTimepoint: 7 days—

Countries

India

Contacts

Public ContactMrs Sudha Vasudevan

Madras Diabetes Research Foundation

s2r_7@mdrf.in04443968487

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026